東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/10 | 2,804 | 2,842 | 2,797 | 2,819 | +8 | +0.3% | 65,500 |
| 2024/06/07 | 2,889 | 2,933 | 2,811 | 2,811 | -78 | -2.7% | 87,600 |
| 2024/06/06 | 2,883 | 2,917 | 2,880 | 2,889 | -19 | -0.7% | 41,500 |
| 2024/06/05 | 2,920 | 2,930 | 2,871 | 2,908 | -45 | -1.5% | 72,500 |
| 2024/06/04 | 2,945 | 2,959 | 2,915 | 2,953 | +19 | +0.6% | 60,700 |
| 2024/06/03 | 2,894 | 2,961 | 2,894 | 2,934 | +44 | +1.5% | 90,700 |
| 2024/05/31 | 2,824 | 2,890 | 2,815 | 2,890 | +67 | +2.4% | 92,700 |
| 2024/05/30 | 2,862 | 2,862 | 2,800 | 2,823 | -39 | -1.4% | 62,400 |
| 2024/05/29 | 2,863 | 2,882 | 2,832 | 2,862 | -12 | -0.4% | 72,100 |
| 2024/05/28 | 2,906 | 2,915 | 2,868 | 2,874 | +18 | +0.6% | 87,400 |
| 2024/05/27 | 2,814 | 2,856 | 2,798 | 2,856 | +42 | +1.5% | 78,800 |
| 2024/05/24 | 2,850 | 2,880 | 2,794 | 2,814 | -3 | -0.1% | 123,000 |
| 2024/05/23 | 2,718 | 2,828 | 2,718 | 2,817 | +108 | +4% | 164,000 |
| 2024/05/22 | 2,710 | 2,726 | 2,698 | 2,709 | -11 | -0.4% | 58,700 |
| 2024/05/21 | 2,730 | 2,756 | 2,698 | 2,720 | -10 | -0.4% | 107,800 |
| 2024/05/20 | 2,740 | 2,784 | 2,718 | 2,730 | -10 | -0.4% | 93,900 |
| 2024/05/17 | 2,620 | 2,763 | 2,604 | 2,740 | +79 | +3% | 196,300 |
| 2024/05/16 | 2,749 | 2,771 | 2,648 | 2,661 | -77 | -2.8% | 146,200 |
| 2024/05/15 | 2,700 | 2,757 | 2,687 | 2,738 | -135 | -4.7% | 445,700 |
| 2024/05/14 | 2,868 | 2,890 | 2,775 | 2,873 | +96 | +3.5% | 314,700 |
| 2024/05/13 | 2,789 | 2,820 | 2,764 | 2,777 | ±0 | ±0% | 182,000 |
| 2024/05/10 | 2,739 | 2,783 | 2,733 | 2,777 | +44 | +1.6% | 73,200 |
| 2024/05/09 | 2,747 | 2,754 | 2,714 | 2,733 | +22 | +0.8% | 75,500 |
| 2024/05/08 | 2,779 | 2,779 | 2,705 | 2,711 | -76 | -2.7% | 88,700 |
| 2024/05/07 | 2,792 | 2,823 | 2,775 | 2,787 | -19 | -0.7% | 93,300 |
| 2024/05/02 | 2,799 | 2,814 | 2,781 | 2,806 | +6 | +0.2% | 49,700 |
| 2024/05/01 | 2,800 | 2,820 | 2,778 | 2,800 | -37 | -1.3% | 80,500 |
| 2024/04/30 | 2,818 | 2,837 | 2,777 | 2,837 | +64 | +2.3% | 105,700 |
| 2024/04/26 | 2,778 | 2,778 | 2,730 | 2,773 | -3 | -0.1% | 94,800 |
| 2024/04/25 | 2,808 | 2,809 | 2,775 | 2,776 | -29 | -1% | 80,900 |
| 2024/04/24 | 2,807 | 2,825 | 2,780 | 2,805 | +10 | +0.4% | 93,000 |
| 2024/04/23 | 2,782 | 2,799 | 2,770 | 2,795 | +3 | +0.1% | 37,700 |
| 2024/04/22 | 2,769 | 2,813 | 2,769 | 2,792 | +42 | +1.5% | 65,800 |
| 2024/04/19 | 2,779 | 2,779 | 2,720 | 2,750 | -29 | -1% | 78,600 |
| 2024/04/18 | 2,751 | 2,795 | 2,751 | 2,779 | +28 | +1% | 49,900 |
| 2024/04/17 | 2,758 | 2,799 | 2,730 | 2,751 | -4 | -0.1% | 83,000 |
| 2024/04/16 | 2,755 | 2,768 | 2,735 | 2,755 | -28 | -1% | 84,500 |
| 2024/04/15 | 2,773 | 2,785 | 2,754 | 2,783 | -31 | -1.1% | 48,000 |
| 2024/04/12 | 2,771 | 2,824 | 2,771 | 2,814 | +43 | +1.6% | 87,400 |
| 2024/04/11 | 2,765 | 2,781 | 2,739 | 2,771 | -8 | -0.3% | 64,200 |
| 2024/04/10 | 2,773 | 2,793 | 2,762 | 2,779 | +9 | +0.3% | 48,400 |
| 2024/04/09 | 2,777 | 2,798 | 2,763 | 2,770 | -7 | -0.3% | 58,700 |
| 2024/04/08 | 2,786 | 2,786 | 2,751 | 2,777 | +32 | +1.2% | 83,700 |
| 2024/04/05 | 2,736 | 2,750 | 2,713 | 2,745 | -3 | -0.1% | 152,700 |
| 2024/04/04 | 2,757 | 2,764 | 2,712 | 2,748 | -9 | -0.3% | 118,100 |
| 2024/04/03 | 2,756 | 2,787 | 2,730 | 2,757 | +1 | ±0% | 155,900 |
| 2024/04/02 | 2,825 | 2,836 | 2,727 | 2,756 | -74 | -2.6% | 164,700 |
| 2024/04/01 | 2,908 | 2,908 | 2,830 | 2,830 | -74 | -2.5% | 99,500 |
| 2024/03/29 | 2,912 | 2,932 | 2,831 | 2,904 | -26 | -0.9% | 162,000 |
| 2024/03/28 | 2,955 | 2,973 | 2,926 | 2,930 | -66 | -2.2% | 123,200 |
201～
250
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
